T Cell therapies 'Heat' up as biotech looks to third public offering
Heat Biologics hopes to raise an additional $14m (€13m) to support its T Cell therapy pipeline made using its allogeneic production platforms.
Archives for February 24, 2016
Unchained Labs continues breaking into biologics market
Unchained Labs has acquired Freeslate, a provider of high-throughput solutions for biologics formulation development and small molecule chemistry – marking the company’s 4th acquisition in 12 months.
Albumedix and Thiologics team up on albumin conjugation tech
A technology collaboration with Thiologics could increase the efficiency and yield of albumin-conjugated drugs, says Novozymes spin-out Albumedix.